Effectiveness of Chromosomal Microarray Analysis for Prenatal Diagnosis of Fetal Echogenic Intracardiac Focus: A Single-Center Experience

References

• Winn VD, Sonson J, Filly RA. Echogenic intracardiac focus: potential for misdiagnosis. J Ultrasound Med. 2003;22(11):1207–1214. doi:10.7863/jum.2003.22.11.1207
   PubMed Web of Science ®Google Scholar
• Maria DR, Paola P, Francesco C, et al. Sonographie marker8 for early diagnosis of fetal malformations. World J Radio. 2013;28(10):356–371.
   Google Scholar
• Bradley KE, Santulli TS, Gregory KD, et al. An isolated intracar-diac echogenic focus as a marker for aneuploidy. Am J Obstet Gynecol. 2005;192(6):2021–2026. doi:10.1016/j.ajog.2005.03.033
   PubMed Web of Science ®Google Scholar
• Rodriguez R, Herrero B, Bartha JL. The continuing enigma of the fetal echogenic intracardiac focus in prenatal ultrasound. Curr Opin Obstet Gynecol. 2013;25(2):145–151. doi:10.1097/GCO.0b013e32835e14eb
   PubMed Web of Science ®Google Scholar
• Benacerraf BR. The role of the second trimester genetic sono-gram in screening for fetal Down syndrome. Semin Perinatol. 2005;29(6):386–394. doi:10.1053/j.semperi.2005.12.003
   PubMed Web of Science ®Google Scholar
• Sood M, Rochelson B, Krantz D, et al. Are second trimester minor sonographic maFkel8 for Down syndrome useful in patients who have undergone fimt-trimester combined screening. Am J Obstet Gynecol. 2010;203(4):408–411. doi:10.1016/j.ajog.2010.05.030
   Web of Science ®Google Scholar
• Lorente AMR, Moreno-Cid M, Rodríguez MJ, et al. Meta-analysis of validity of echogenic intracardiac foci for calculating the risk of down syndrome in the second trimester of pregnancy. Taiwan J Obstet Gynecol. 2017;56(1):16–22. doi:10.1016/j.tjog.2016.11.002
   PubMed Web of Science ®Google Scholar
• Winter TC, Anderson AM, Cheng EY, et al. Echogenic intracardiac focus in 2nd-trimester fetuses with trisomy 21: usefulness as a US marker. Radiology. 2000;216(2):450–456. doi:10.1148/radiology.216.2.r00au32450
   PubMed Web of Science ®Google Scholar
• Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol. 2013;41(3):247–261. doi:10.1002/uog.12364
   PubMed Web of Science ®Google Scholar
• Chiu G, Zhao A, Zhang B, Zhang T. Intracardiac echogenic focus and its location: association with congenital heart defects. J Matern Fetal Neonatal Med. 2019;32(18):3074–3078. doi:10.1080/14767058.2018.1558200
   PubMed Web of Science ®Google Scholar
• Bettelheim D, Deutinger J, Bernaschek G. The value of echogenic foci (‘golfballs’) in the fetal heart as a marker of chromosomal abnormalities. Ultrasound Obstet Gynecol. 1999;14(2):98–100. doi:10.1046/j.1469-0705.1999.14020098.x
   PubMed Web of Science ®Google Scholar
• Levy B, Wapner R. Prenatal diagnosis by chromosomal microarray analysis. FertilSteril. 2018;109(2):201–212.
   PubMed Web of Science ®Google Scholar
• Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175–2184. doi:10.1056/NEJMoa1203382
   PubMed Web of Science ®Google Scholar
• Pauta M, Grande M, Rodriguez-Revenga L, Kolomietz E, Borrell A. Added value of chromosomal microarray analysis over karyotyping in early pregnancy loss: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(4):453–462. doi:10.1002/uog.18929
   PubMed Web of Science ®Google Scholar
• Huang H, Cai M, Wang Y, Liang B, Lin N, Xu L. SNP array as a tool for prenatal diagnosis of congenital heart disease screened by echocardiography: implications for precision assessment of fetal prognosis. Risk Manag Healthc Policy. 2021;14:345–355. doi:10.2147/RMHP.S286001
   PubMed Web of Science ®Google Scholar
• Mirza FG, Ghulmiyyah L, Tamim H, et al. Echogenic intracardiac focus on second trimester ultrasound: prevalence and significance in a Middle Eastern population. J Matern Fetal Neonatal Med. 2016;29(14):2293–2296. doi:10.3109/14767058.2015.1083549
   PubMed Web of Science ®Google Scholar
• Wei M, Zhang J, Liu ZY, et al. Correlation between fetal intracardiac echogenic foci and chromosome and heart function. Chin Med J. 2018;98(47):3864–3867.
   Google Scholar
• Wax JR, Donnelly J, Carpenter M, et al. Childhood cardiac function after prenatal diagnosis of intracardiac echogenic foci. J Ultrasound Med. 2003;22(8):783–787. doi:10.7863/jum.2003.22.8.783
   PubMed Web of Science ®Google Scholar
• Degani S, Leibovitz Z, Shapiro I, Gonen R, Ohel G. Cardiac function in fetuses with intracardiac echogenic foci. Ultrasound Obstet Gynecol. 2001;18(2):131–134. doi:10.1046/j.1469-0705.2001.00433.x
   PubMed Web of Science ®Google Scholar
• Wolman I, Jaffa A, Geva E, et al. Intracardiac echogenic focus: no apparent association with structural cardiac abnormality. Fetal Diagn Ther. 2000;15(4):216–218. doi:10.1159/000021009
   PubMed Web of Science ®Google Scholar
• Carriço A, Matias A, Areias JC. How important is a cardiac echogenic focus in a routine fetal examination? Rev Port Cardiol. 2004;23(3):459–461.
   PubMedGoogle Scholar
• Chitra N, Vijayalakshmi IB. Fetal echocardiography for early detection of congenital heart diseases. J Echocardiogr. 2017;15(1):13–17. doi:10.1007/s12574-016-0308-2
   PubMed Web of Science ®Google Scholar
• Norton ME. Follow-up of sonographically detected soft markers for fetal aneuploidy. SeminPerinatol. 2013;37(5):365–369.
   Google Scholar
• Stefanovic V. Soft markers for aneuploidy following reassuring first trimester screening: what should be done? Curr Opin Obstet Gynecol. 2015;27(2):151–158.
   PubMed Web of Science ®Google Scholar
• Lin CZ, Qi BR, Hu JS, Huang YD, Huang XQ. Chromosome 15q13 microduplication in a fetus with cardiac rhabdomyoma: a case report. MolCytogenet. 2019;12:24.
   Google Scholar
• Xie Y, Sun X. Chromosomal microarray analysis in prenatal diagnosis. Clin Exp Obstet Gynecol. 2017;44(2):177–179.
   PubMed Web of Science ®Google Scholar
• Dugoff L, Norton ME, Kuller JA. The use of chromosomal microarray for prenatal diagnosis. Am J Obstet Gynecol. 2016;215(4):B2–B9. doi:10.1016/j.ajog.2016.07.016
   PubMed Web of Science ®Google Scholar
• Lo JO, Shaffer BL, Feist CD, Caughey AB. Chromosomal microarray analysis and prenatal diagnosis. Obstet Gynecol Surv. 2014;69(10):613–621.
   PubMed Web of Science ®Google Scholar
• Chen CP, Hsu CY, Chern SR, Wu PS, Chen SW, Wang W. Prenatal diagnosis of mosaic trisomy 8 by amniocentesis in a fetus with ventriculomegaly and dysgenesis of the corpus callosum. Taiwan J Obstet Gynecol. 2020;59(1):127–129. doi:10.1016/j.tjog.2019.11.020
   PubMed Web of Science ®Google Scholar
• Saks E, Mccoy MC, Damron J, Kelly TE. Confined placental mosaicism for trisomy 8 and intra-uterine growth retardation. Prenat Diagn. 1998;18(11):1202–1204.
   PubMed Web of Science ®Google Scholar
• Eggermann T, Soellner L, Buiting K, Kotzot D. Mosaicism and uniparentaldisomy in prenatal diagnosis. Trends Mol Med. 2015;21(2):77–87. doi:10.1016/j.molmed.2014.11.010
   PubMed Web of Science ®Google Scholar
• Verma RS, Kleyman SM, Conte RA. Chromosomal mosaicisms during prenatal diagnosis. Gynecol Obstet Invest. 1998;45(1):12–15. doi:10.1159/000009915
   PubMed Web of Science ®Google Scholar
• Huber C, Cusin V, Le Merrer M, et al. SHOX point mutations in dyschondrosteosis. J Med Genet. 2001;38(5):323. doi:10.1136/jmg.38.5.323
   PubMed Web of Science ®Google Scholar
• Falcinelli C, Iughetti L, Percesepe A, et al. SHOX point mutations and deletions in Leri-Weill dyschondrosteosis. J Med Genet. 2002;39(6):E33. doi:10.1136/jmg.39.6.e33
   PubMedGoogle Scholar
• Leavitt K, Goldwaser T, Bhat G, Kalia I, Klugman SD, Dolan SM. Chromosomal microarray in prenatal diagnosis: case studies and clinical challenges. Per Med. 2016;13(3):249–255. doi:10.2217/pme-2015-0003
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443–456. doi:10.1542/peds.2009-2959
   PubMed Web of Science ®Google Scholar
• Clift K, Macklin S, Halverson C, McCormick JB, Abu Dabrh AM, Hines S. Patients’ views on variants of uncertain significance across indications. J Commun Genet. 2020;11(2):139–145. doi:10.1007/s12687-019-00434-7
   PubMed Web of Science ®Google Scholar
• Smith AE, Jnah A, Newberry D. Chromosome 16p13.11 microdeletionsyndrome in a newborn: a case study. Neonatal Netw. 2018;37(5):303–309. doi:10.1891/0730-0832.37.5.303
   PubMed Web of Science ®Google Scholar
• Nagamani SC, Erez A, Bader P, et al. Phenotypic manifestations of copy number variation in chromosome 16p13.11. Eur J Hum Genet. 2011;19(3):280–286. doi:10.1038/ejhg.2010.184
   PubMed Web of Science ®Google Scholar
• Yu A, Turbiville D, Xu F, et al. Genotypic and phenotypic variability of 22q11.2 microduplications: an institutional experience. Am J Med Genet A. 2019;179(11):2178–2189. doi:10.1002/ajmg.a.61345
   PubMed Web of Science ®Google Scholar